Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Naohito, Yamasaki"'
Autor:
Yuichi Baba, Yuri Ochi, Juri Kawaguchi, Azumi Takiishi, Daigo Hirakawa, Toru Kubo, Naohito Yamasaki, Hiroaki Kitaoka
Publikováno v:
Cardiovascular Ultrasound, Vol 22, Iss 1, Pp 1-6 (2024)
Abstract Background Echocardiography remains the reference-standard imaging technique for assessing valvular heart disease (VHD), but artifacts like the ‘color Doppler stripe’ can complicate diagnosis. This artifact is not widely recognized and c
Externí odkaz:
https://doaj.org/article/b5f3f93e145547279d8dc58a9359a2ea
Autor:
Kenta Sugiura, Toru Kubo, Yuri Ochi, Kazuya Miyagawa, Yuichi Baba, Tatsuya Noguchi, Takayoshi Hirota, Naohito Yamasaki, Yoshinori L. Doi, Hiroaki Kitaoka
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2618-2625 (2022)
Abstract Aims We aim to clarify the prognosis on patients with hypertrophic cardiomyopathy (HCM) for a follow‐up period of more than 10 years. Methods and results We retrospectively analysed 102 consecutive patients with HCM diagnosed by 31 Decembe
Externí odkaz:
https://doaj.org/article/717c54cba80a4f55857fe6373b35acf1
Autor:
Toru Kubo, Yuichi Baba, Yuri Ochi, Takayoshi Hirota, Naohito Yamasaki, Kazuya Kawai, Katsuhito Yamamoto, Fumiaki Kondo, Kanji Bando, Eisuke Yamada, Takashi Furuno, Toshikazu Yabe, Yoshinori L. Doi, Hiroaki Kitaoka
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 5022-5030 (2021)
Abstract Aims There is limited information about the clinical significance of atrial fibrillation (AF), particularly new‐onset AF, in patients with hypertrophic cardiomyopathy (HCM) in a community‐based patient cohort. This study was carried out
Externí odkaz:
https://doaj.org/article/1c4b510648f84e658f0bdb2278c7577d
Autor:
Toru Kubo, Yuri Ochi, Yuichi Baba, Kenta Sugiura, Asa Takahashi, Takayoshi Hirota, Shigeo Yamanaka, Naohito Yamasaki, Yoshinori L. Doi, Hiroaki Kitaoka
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 3593-3600 (2020)
Abstract Aims Hypertrophic cardiomyopathy (HCM) is generally associated with mild disability and normal life expectancy. On the other hand, once the end‐stage phase of HCM characterized by left ventricular (LV) ejection fraction 1 year. HCM progres
Externí odkaz:
https://doaj.org/article/9f82aa7c2397407db474cc264fe09b32
Autor:
Azumi Takiishi, Yuichi Baba, Yuri Ochi, Mizuki Hotta, Nagisa Okazaki, Yuna Yoshinaga, Shohei Miyamoto, Daigo Hirakawa, Juri Kawaguchi, Toru Kubo, Naohito Yamasaki, Shinji Tokuhiro, Hiroaki Kitaoka
Publikováno v:
Echocardiography; Apr2024, Vol. 41 Issue 4, p1-7, 7p
Autor:
Kenta Sugiura, Toru Kubo, Yuri Ochi, Yuichi Baba, Takayoshi Hirota, Naohito Yamasaki, Hiroaki Kitaoka
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 25, Iss , Pp 100662- (2020)
Background: Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disease caused by a deficiency of the lysosomal enzyme α-L-iduronidase. Cardiac manifestations such as valvular heart disease are associated with poor prognosis. There ha
Externí odkaz:
https://doaj.org/article/df25cf6fd55843269fd3aeadfd072811
Autor:
Toru, Kubo, Masashi, Amano, Seiji, Takashio, Takahiro, Okumura, Saori, Yamamoto, Takeru, Nabeta, Masayoshi, Oikawa, Satoshi, Kurisu, Yuri, Ochi, Kenta, Sugiura, Yuichi, Baba, Hajime, Kuroiwa, Takayoshi, Hirota, Naohito, Yamasaki, Shunsuke, Ishii, Kotaro, Nochioka, Yasuchika, Takeishi, Satoshi, Yasuda, Kenichi, Tsujita, Chisato, Izumi, Hiroaki, Kitaoka
Publikováno v:
Journal of Cardiology. 80:325-331
The prevalence of Fabry disease (FD) in male patients with left ventricular hypertrophy (LVH) is about 1%. From the perspective of performing more efficient screening with measurement of α-galactosidase (α-Gal) activity, it is important to raise th
Autor:
Yuichi Baba, Toru Kubo, Yuri Ochi, Takayoshi Hirota, Naohito Yamasaki, Hiroshi Ohnishi, Tetsuya Kubota, Akihito Yokoyama, Hiroaki Kitaoka
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 21, p3097-3105, 9p
Autor:
Naoki Arima, Yuri Ochi, Makoto Takahashi, Toshihiro Moriki, Tatsuya Noguchi, Toru Kubo, Naohito Yamasaki, Hiroaki Kitaoka
Publikováno v:
European Heart Journal - Case Reports. 7
Background In patients with apical hypertrophic cardiomyopathy (HCM), electrocardiography (ECG) often shows left ventricular hypertrophy (LVH) and a negative T wave. A negative T wave often disappears over time due to degeneration of the apical myoca
Autor:
Hiroaki Kitaoka, Kazuya Kawai, Eisuke Yamada, Toshikazu Yabe, Takashi Furuno, Yuichi Baba, Naohito Yamasaki, Toru Kubo, Yuri Ochi, Fumiaki Kondo, Takayoshi Hirota, Kanji Bando, Yoshinori Doi, Katsuhito Yamamoto
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 5022-5030 (2021)
ESC Heart Failure
ESC Heart Failure
Aims There is limited information about the clinical significance of atrial fibrillation (AF), particularly new‐onset AF, in patients with hypertrophic cardiomyopathy (HCM) in a community‐based patient cohort. This study was carried out to clarif